May 8, 2020
Nathaniel Van Kirk, PhD
and
May 13, 2020
Igor Galynker, MD, PhD
and
April 9, 2020
Rachel Busman, PsyD
and
Jami M. Furr, Ph.D.
and
September 10, 2020
Rachel Singer, PhD
and
January 16, 2020
Paul Holtzheimer, MD - ADAA Board Member
and
Deep brain stimulation (DBS) is emerging as a potential intervention for patients with highly treatment-resistant depression (TRD). Early, open-label studies supported the safety and potential efficacy of DBS for TRD but later randomized, controlled trials have yielded mixed results.
September 26, 2019
May 23, 2019
April 10, 2019
Dean McKay, PhD, ABPP
and
March 7, 2019
Sheila Rauch, PhD, ABPP
and
January 10, 2019
